Shares of Trulieve Cannabis Corp (OTC: TCNNF) surged 14.1% on Tuesday, contrasting with a 0.3% decline in the S&P 500 and a 0.2% gain in the Nasdaq Composite. The increase follows President Donald Trump’s confirmation that his administration is considering reclassifying cannabis to Schedule III, a move that could significantly impact the cannabis industry and Trulieve’s operations. Trump mentioned the potential change during a press briefing, noting public interest in the matter.
